AllFrontierGlobalAll FTAs ↗

India-EFTA TEPA

Curated by Vinod Kumar Jain & Amit Jain · All Frontier Global · free, no login

Chapter-by-chapter intelligence on the India-EFTA TEPA — status: signed-pending-ratification. What each chapter changes for Indian exporters and importers.

Trade in Goods: TEPA Goods chapter is signed — first India FTA with Switzerland-led EFTA bloc; gold + watches are the headline EFTA exports.

The Trade and Economic Partnership Agreement (TEPA) Goods chapter signed March 2024 covers India + EFTA-4 (Switzerland, Norway, Iceland, Liechtenstein), with phased tariff elimination on most bilateral lines, gold + watches + chocolate as headline EFTA exports, Indian textile + agriculture + processed foods as principal Indian-side exports.

India advantage: Indian textiles, leather, gems & jewellery, agriculture, processed foods, pharma generics gain duty-free or near-zero EFTA-4 access; EFTA-4 commitment to invest USD 100B in India over 15 years (the world's first FTA-anchored binding investment commitment of this scale).

Next milestone: TEPA entry-into-force target 2026 (subject to ratification); first review windows Year-3 + Year-5 post-entry-into-force.

Services + Mode 4: Services chapter covers IT services + financial services + education with EFTA-4 specific commitments; small-but-deep services flow.

The Services + Mode-4 chapter under TEPA covers IT services + financial services + education + healthcare commitments across EFTA-4; Switzerland is the dominant services-trade partner (financial + pharma R&D + watch industry); Norway adds petroleum services + maritime; Iceland + Liechtenstein add specialty services.

India advantage: Indian IT-services majors gain Swiss + EFTA-4 mobility commitments; healthcare professionals (nurses, accountants) gain mutual-recognition pathway; Indian banks + financial services gain EFTA-4 establishment commitments.

Next milestone: Services chapter entry-into-force target 2026; mutual-recognition working groups continue.

Investment Protection: TEPA distinctive feature: USD 100B EFTA-4 investment commitment over 15 years — the world's first FTA-anchored binding investment target.

TEPA Chapter on Investment includes the world's first FTA-anchored binding investment commitment: EFTA-4 commits to facilitate USD 100B in foreign direct investment into India over 15 years post-entry-into-force, with milestone reviews; standard national-treatment + MFN + expropriation provisions sit alongside this commercial commitment.

India advantage: India secures binding USD 100B investment-flow commitment from EFTA-4 (largely Switzerland-led) — distinctive global FTA precedent; commercial-investment commitment provides job-creation justification for the FTA.

Next milestone: TEPA entry-into-force target 2026; first 5-year investment commitment milestone review 2031.

Trade Remedies + ROO Compliance: TEPA Trade Remedies + ROO chapter standardised; Swiss-led approach mirrors EFTA bilateral templates.

TEPA Trade Remedies chapter preserves WTO ADD + CVD + safeguards rights with cooperation provisions; ROO chapter follows EFTA bilateral template (CTH + RVC dual qualification with PSR for sensitive sectors); bilateral safeguard mechanism with 4-year application.

India advantage: India retains global trade-remedy authority; ROO discipline limits third-country rerouting via EFTA-4 (especially Switzerland as financial-services hub); Swiss watch + gold ROO scrutiny tightened.

Next milestone: TEPA entry-into-force target 2026; first ROO review Year-3.

IP + Digital Trade: TEPA IP chapter distinctive: Switzerland-led TRIPS-plus push tempered by Indian generic-pharma protection — compromise text reached.

TEPA Chapter on IP covers patents, trademarks, copyrights, designs, GIs at TRIPS-plus levels with Swiss-led innovator-drug protection emphasis; the digital-trade chapter targets cross-border data flows + paperless-trade with Swiss financial-services + Norwegian-petroleum-services digital standards.

India advantage: India retains TRIPS flexibilities (Section 3(d), compulsory licensing) — generic-pharma sector protection preserved despite Swiss TRIPS-plus push; GI mutual-recognition for Indian appellations.

Next milestone: TEPA entry-into-force target 2026; IP cooperation working group implementation post-EIF.